Against the intrauterine pressure catheter, INVU detected contractions more accurately than TOCO and was not affected by BMI.
Uterine activity derived from INVU’s ECG and acoustic signals tracked the intrauterine catheter closely.
In 147 women, INVU fetal and maternal heart rate agreed closely with CTG (fetal heart rate r = 0.92).
Registered comparison of INVU contraction monitoring with the catheter (80 enrolled).
Registered pivotal comparison with CTG at sites in Germany, Israel and the US (151 enrolled).
We wrote short, plain-language summaries of 3 of the 5 papers on this page. Each one opens the summary, with a link to the full paper inside. In the list above, look for “Summary →”.
INVU derives uterine activity from the mother’s heart signals, electrical and acoustic, rather than from a pressure belt.
Read the summary →
INVU’s contraction monitoring was tested in 118 women (78 in the validation phase) against the intrauterine pressure catheter, the clinical reference.
Read the summary →
In 147 pregnant women, fetal and maternal heart rates recorded with INVU were compared with standard cardiotocography (CTG).
Read the summary →More about INVU™ beyond the published research.
Whether you would like to know more about INVU™, explore a research collaboration, or partner with us, we would love to hear from you.
Email info@nuvocares.com ↗